Malignant Uveal Neoplasm — Trials

Malignant Uveal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 29
Ph III recruiting: 6
Growth YoY: —
Industry share: 36%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (34)

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00072345	Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma	completed	Phase 2	—	Memorial Sloan Kettering Cancer CenterOTHER	1	Jan 18, 2013	clinicaltrials
NCT00003802	Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma	completed	Phase 2	—	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Dec 17, 2012